N1-(4-(4-(4-fluorophenyl)-2-(methylthio)-1H-imidazol-5-yl)pyridin-2-yl)benzene-1,4-diamine

ID: ALA4074524

Chembl Id: CHEMBL4074524

PubChem CID: 137641182

Max Phase: Preclinical

Molecular Formula: C21H18FN5S

Molecular Weight: 391.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccc(N)cc3)c2)[nH]1

Standard InChI:  InChI=1S/C21H18FN5S/c1-28-21-26-19(13-2-4-15(22)5-3-13)20(27-21)14-10-11-24-18(12-14)25-17-8-6-16(23)7-9-17/h2-12H,23H2,1H3,(H,24,25)(H,26,27)

Standard InChI Key:  ZTEDFSIIEDNHLZ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4074524

    ---

Associated Targets(Human)

MAPK10 Tchem c-Jun N-terminal kinase 3 (3396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.48Molecular Weight (Monoisotopic): 391.1267AlogP: 5.33#Rotatable Bonds: 5
Polar Surface Area: 79.62Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.97CX Basic pKa: 6.00CX LogP: 4.90CX LogD: 4.88
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.32Np Likeness Score: -1.37

References

1. Muth F, El-Gokha A, Ansideri F, Eitel M, Döring E, Sievers-Engler A, Lange A, Boeckler FM, Lämmerhofer M, Koch P, Laufer SA..  (2017)  Tri- and Tetrasubstituted Pyridinylimidazoles as Covalent Inhibitors of c-Jun N-Terminal Kinase 3.,  60  (2): [PMID:27977190] [10.1021/acs.jmedchem.6b01180]
2. Ahamad S, Bhat SA..  (2022)  The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease.,  65  (24.0): [PMID:36490325] [10.1021/acs.jmedchem.2c00799]

Source